ÂÜÀòÂÒÂ×

Elena Clementi is a product developer at Oncobit AG since April 2021, with a strong background in cancer biology. Elena obtained a PhD in Cancer Biology from the University of Zurich, focusing on Base Excision Repair (BER) and its critical role in fibroblast homeostasis. Prior to this, Elena completed a Master's degree in Cellular and Molecular Biotechnology and a Bachelor's degree in Biomolecular Sciences and Technology, both at the University of Trento. Elena's research experience includes conducting an internship at CIBIO in the laboratory of Molecular Neuropathology and exploring the role of growth hormone dysfunction in a model for autism spectrum disorders during their graduate studies.